Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003041340 | SCV003442553 | pathogenic | not provided | 2022-04-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with Perrault syndrome (PMID: 27899912). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala10Profs*117) in the CLPP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLPP are known to be pathogenic (PMID: 23851121, 27899912). |
Kasturba Medical College, |
RCV005051999 | SCV005684974 | pathogenic | Perrault syndrome 3 | criteria provided, single submitter | research | A known frameshift variant, c.21del (Domínguez-Ruiz M et al., 2019; Clinvar ID: 2138190) in exon 1 of CLPP gene was observed in homozygous state in proband. On segregation, the variant was observed in heterozygous state in his parents. This variant is observed heterozygous state in 6 individuals in gnomAD (v4.1.0) population database (allele frequency:0.000004247). The variant c.21del is absent in our in-house data of 3479 exomes. |